Literature DB >> 8738801

Renal interstitial sclerosis in aging: effects of enalapril and nifedipine.

F Inserra1, L A Romano, E M de Cavanagh, L Ercole, L F Ferder, R A Gomez.   

Abstract

The effects of nifedipine and enalapril on age-associated renal interstitial fibrosis were investigated in 60 CF1 female mice. Mice received 20 mg enalapril (ENAL) per L (N = 20), or 40 mg nifedipine (NIF) per L (N = 20) in their drinking water. Control (CONT) mice received tap water ad libitum. The percentages of both interstitial peritubular sclerosis (IPS) in cortex and interstitial medullary sclerosis (IMS) were determined. Kidney tissue was studied using immunological techniques and optical (OM) and electron microscopy (EM) to analyze the expression of renin. alpha-SM-actin and vimentine expression were also evaluated. The results showed that blood pressure levels in ENAL or NIF animals were not different from those of CONT. Renin expression was observed in arcuate vessels (AV) in ENAL animals, whereas no renin staining in AV was found in either NIF or CONT animals. Renin immunoreactivity in the juxtaglomerular apparatus was more intense in ENAL mice, as compared with NIF or CONT animals. Laboratory testing showed the following values: proteinuria (mg/mL): CONT 6.1 +/- 0.6, NIF 11.2 +/- 2.3, and ENAL 1.0 +/- 0.6 (P < 0.05); creatinine: CONT 1.37 +/- 0.24, NIF 0.87 +/- 0.16, and ENAL 0.63 +/- 0.1 (P < 0.01). The percentages of interstitial sclerosis were: %IPS: CONT 18.12 +/- 1.1, NIF 17.40 +/- 0.9, and ENAL 3.42 +/- 1.3 (P < 0.01); %IMS: CONT 23.41 +/- 1.5, NIF 21.80 +/- 1.9, and ENAL 6.12 +/- 1.2 (P < 0.01). Percentages of alpha-SM-actin expression were: CONT 13.10 +/- 1.9, NIF 13.80 +/- 0.2, and ENAL 1.00 +/- 0.1 (P < 0.01). Vimentine staining showed no differences among the groups. It was concluded that enalapril reduces the peritubular and medullar interstitial fibrosis, whereas nifedipine has no effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738801     DOI: 10.1681/ASN.V75676

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

1.  Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction.

Authors:  Christy S Carter; Leanne Groban
Journal:  Aging health       Date:  2008-02-01

Review 2.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Design of aging intervention studies: the NIA interventions testing program.

Authors:  N L Nadon; R Strong; R A Miller; J Nelson; M Javors; Z D Sharp; J M Peralba; D E Harrison
Journal:  Age (Dordr)       Date:  2008-04-18

4.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

Review 5.  Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia.

Authors:  Christy S Carter; Emanuele Marzetti; Christiaan Leeuwenburgh; Todd Manini; Thomas C Foster; Leanne Groban; Philip J Scarpace; Drake Morgan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-02       Impact factor: 6.053

Review 6.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

7.  Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.

Authors:  Emanuele Marzetti; Riccardo Calvani; Jameson DuPree; Hazel A Lees; Silvia Giovannini; Dong-oh Seo; Thomas W Buford; Kindal Sweet; Drake Morgan; Kevin Y E Strehler; Debra Diz; Stephen E Borst; Natasha Moningka; Karina Krotova; Christy S Carter
Journal:  Age (Dordr)       Date:  2012-05-26

8.  An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis.

Authors:  Olga I Santiago; Edelmarie Rivera; Leon Ferder; Caroline B Appleyard
Journal:  Regul Pept       Date:  2007-10-23

9.  Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.

Authors:  Dominique Guerrot; Jean-Claude Dussaule; Mouna Mael-Ainin; Yi-Chun Xu-Dubois; Eric Rondeau; Christos Chatziantoniou; Sandrine Placier
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 10.  The renin-angiotensin system and aging in the kidney.

Authors:  Hye Eun Yoon; Bum Soon Choi
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.